Outpatients with cirrhosis for Cirrhosis of the Liver

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Cirrhosis of the Liver+3 More
Sensor skin - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Longitudinal monitoring of inflammation using skin devices may help predict outcomes compared to traditional blood draws

Eligible Conditions

  • Cirrhosis of the Liver

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Cirrhosis of the Liver

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 3 days

3 days
Ability to detect inflammatory markers (TNF, IL-1b, IL-6 and CRP) using skin sensor compared to blood values
Linkage of inflammatory markers (TNF, IL-6, IL-1b and CRP) with cognitive testing
Linkage of inflammatory markers with MELD score
Linkage of skin inflammatory markers (TNF, IL-6, IL-1b and CRP) with quality of life
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

Trial Safety

Safety Progress

1 of 3

Other trials for Cirrhosis of the Liver

Trial Design

3 Treatment Groups

Outpatients with cirrhosis
1 of 3
Inpatients with cirrhosis
1 of 3
Healthy controls
1 of 3
Experimental Treatment

60 Total Participants · 3 Treatment Groups

Primary Treatment: Outpatients with cirrhosis · No Placebo Group · N/A

Outpatients with cirrhosis
DiagnosticTest
Experimental Group · 1 Intervention: Sensor skin · Intervention Types: DiagnosticTest
Inpatients with cirrhosis
DiagnosticTest
Experimental Group · 1 Intervention: Sensor skin · Intervention Types: DiagnosticTest
Healthy controls
DiagnosticTest
Experimental Group · 1 Intervention: Sensor skin · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 days
Closest Location: Hunter Holmes McGuire VA Medical Center · Richmond, VA
Photo of Richmond  1Photo of Richmond  2Photo of Richmond  3
2003First Recorded Clinical Trial
16 TrialsResearching Cirrhosis of the Liver
60 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are healthy.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.